Efficacy of Majoon-e-Sarakhs in Primary Hypothyroidism

Evaluation of the add on effect of Majoon-e-Sarakhs with levothyroxine in Primary Hypothyroidism

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011962

Enrollment

100

Registered

2018-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed cases of Primary Hypothyroidism

Interventions

Intervention1: Majoon-e-Sarakhs and levothyroxine: Oral Route: Dose: 10 gm twice a day Oral Route: 1.6 Î¼g/kg Body weight /day Control Intervention1: levothyroxine: Oral Route: 1.6 Î¼g/kg Body Weight

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed patients of Qillat-e-Ifraz-e- Darqiyya Ibtidai 2. TSH >5 and 3. Patient of both sexes. 4. Patient in age group of 18 to 45 years. 5. Patients able to participate in the study and ready to follow the instructions and sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating mothers. 2. TSH 15ÂµIU/ml 3. Patients below 18 and above 45 years 4. Complicated cases of hypothyroidism. 5. Known cases of metabolic and systemic diseases 6. Hyperthyroidism. 7. Patients who fail to give consent.

Design outcomes

Primary

Measure	Time frame
Decreased level of TSHTimepoint: Follow Up: 0th , 30th , 45th and 60th day	—

Secondary

Measure	Time frame
Changes in Subjective parametersTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Mohd Aleemuddin Quamri

National Institute of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026